Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penford Australia was a leading manufacturer and supplier of specialty starch-based ingredients for the pharmaceutical, food, and industrial sectors in the Asia-Pacific region. The company specialized in the production of modified starches that served as critical excipients in pharmaceutical manufacturing, specifically acting as binders, disintegrants, and fillers for solid dosage forms. Originally operating as Starch Australasia, the company became a key subsidiary of the U.S.-based Penford Corporation, providing technical expertise in carbohydrate chemistry. In 2015, the company was integrated into Ingredion following the global acquisition of its parent corporation. Its operations were centered around major manufacturing facilities in New South Wales, supporting the regional healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penford Australia.